Videos
What can we help you find?
The panel reflects on the role of a pharmacist in the identification and management of opioid-induced constipation.
Expert physicians and pharmacists consider the frontline treatment approach, with special consideration of the roleo f frontline neoadjuvant chemotherapy in treating individuals with ovarian cancer.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how Specialty Pharmacists can drive the data standardization conversation during the NASP Annual Meeting in Washington, DC.
Shared insight on the open dialogues that should take place between patients with opioid-induced constipation and care providers.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss during the future of data in Specialty Pharmacy at the NASP Annual Meeting in Washington, DC.
A discussion on the typical diagnostic work-up, including CT scan, tumor markers, colonoscopy, germline, and somatic testing.
Jesse C. Dresser, Esq explains a recent piece of PBM legislation from North Dakota and its implications for specialty pharmacy at the NASP Annual Meeting in Washington, DC.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about 3 professional accomplishments he and his business have achieved.
Key opinion leaders provide an overview of ovarian cancer and consider the associated risk factors.
Key opinion leaders provide their perspectives on the goals of therapy and prophylactic management of opioid-induced constipation.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss value-based care and whether or not it poses challenge to data standardization in specialty pharmacy during the NASP Annual Meeting in Washington, DC.